Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-31 Option Award | 2024-11-01 4:31 pm | N/A 2034-10-31 | Carisma Therapeutics Inc. | CARM | Cheng Sohanya Roshan Director | 38,700 | $0 | 38,700 (Direct) | View |
2024-07-01 Option Award | 2024-07-01 7:19 pm | N/A 2034-07-01 | Carisma Therapeutics Inc. | CARM | Thorell Marella Director | 38,700 | $0 | 38,700 (Direct) | View |
2024-07-01 Option Award | 2024-07-01 7:17 pm | N/A 2034-07-01 | Carisma Therapeutics Inc. | CARM | Scadden David Director | 38,700 | $0 | 38,700 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:56 pm | N/A 2034-06-26 | Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director | 19,350 | $0 | 19,350 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:54 pm | N/A 2034-06-26 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 19,350 | $0 | 19,350 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:53 pm | N/A 2034-06-26 | Carisma Therapeutics Inc. | CARM | Hohneker John Director | 19,350 | $0 | 19,350 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:51 pm | N/A 2034-06-26 | Carisma Therapeutics Inc. | CARM | Torok Michael Director | 19,350 | $0 | 19,350 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 7:08 pm | N/A 2034-06-17 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 7:06 pm | N/A 2034-06-17 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 85,000 | $0 | 85,000 (Direct) | View |
2024-06-17 Option Award | 2024-06-18 7:05 pm | N/A 2034-06-17 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 125,000 | $0 | 125,000 (Direct) | View |
2024-04-01 Option Award | 2024-04-01 6:59 pm | N/A 2034-04-01 | Carisma Therapeutics Inc. | CARM | Hohneker John Director | 38,700 | $0 | 38,700 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:53 pm | N/A 2034-01-31 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 170,500 | $0 | 170,500 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:53 pm | N/A 2034-01-31 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 170,500 | $0 | 170,500 (Direct) | View |
2024-01-31 Option Award | 2024-02-02 4:52 pm | N/A 2034-01-31 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 438,000 | $0 | 438,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:20 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:19 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director | 38,700 | $0 | 38,700 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:18 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 238,000 | $0 | 238,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:16 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Torok Michael Director | 38,700 | $0 | 38,700 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:15 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 238,000 | $0 | 238,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:13 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Ugwumba Chidozie Director | 38,700 | $0 | 38,700 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 6:11 pm | N/A 2033-06-06 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 38,700 | $0 | 38,700 (Direct) | View |
Ownership | 2023-03-13 5:06 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | ModernaTX Inc. 10% Owner | 0 | $0 | 5,059,338 (Direct) | View |
2023-03-07 Option Award | 2023-03-09 9:32 pm | N/A 2028-09-18 | Carisma Therapeutics Inc. | CARM | Kelly Steven President and CEO | 1,041,765 | $0 | 1,041,765 (Direct) | View |
2023-03-07 Option Award | 2023-03-09 9:31 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | Ugwumba Chidozie Director | 2,215,877 | $0 | 2,215,877 (Indirect) | View |
2023-03-07 Option Award | 2023-03-09 9:29 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | Hodits Regina Director | 2,297,546 | $0 | 2,297,546 (Indirect) | View |
2023-03-07 Option Award | 2023-03-09 9:27 pm | N/A 2027-11-01 | Carisma Therapeutics Inc. | CARM | Klichinsky Michael Chief Scientific Officer | 729,369 | $0 | 729,369 (Direct) | View |
2023-03-07 Option Award | 2023-03-09 9:26 pm | N/A 2031-05-31 | Carisma Therapeutics Inc. | CARM | Morris Richard Steven Chief Financial Officer | 331,114 | $0 | 331,114 (Direct) | View |
2023-03-07 Option Award | 2023-03-09 9:25 pm | N/A N/A | Carisma Therapeutics Inc. | CARM | Torok Michael Director | 421,241 | $0 | 101,250 (Direct) | View |
2023-03-07 Option Award | 2023-03-09 9:23 pm | N/A 2031-11-08 | Carisma Therapeutics Inc. | CARM | ZWEIFACH SANFORD S Director | 185,034 | $0 | 185,034 (Direct) | View |
2023-03-07 Option Award | 2023-03-09 9:21 pm | N/A 2030-07-23 | Carisma Therapeutics Inc. | CARM | Morrison Briggs Director | 109,674 | $0 | 109,674 (Direct) | View |